Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications

Ramesh C Gupta, Dennis Chang, Srinivas Nammi, Alan Bensoussan, Kellie Bilinski, Basil D Roufogalis, Ramesh C Gupta, Dennis Chang, Srinivas Nammi, Alan Bensoussan, Kellie Bilinski, Basil D Roufogalis

Abstract

Diabetes is a complex condition with a variety of causes and pathophysiologies. The current single target approach has not provided ideal clinical outcomes for the treatment of the disease and its complications. Herbal medicine has been used for the management of various diseases such as diabetes over centuries. Many diabetic patients are known to use herbal medicines with antidiabetic properties in addition to their mainstream treatments, which may present both a benefit as well as potential risk to effective management of their disease. In this review we evaluate the clinical and experimental literature on herb-drug interactions in the treatment of diabetes. Pharmacokinetic and pharmacodynamic interactions between drugs and herbs are discussed, and some commonly used herbs which can interact with antidiabetic drugs summarised. Herb-drug interactions can be a double-edged sword presenting both risks (adverse drug events) and benefits (through enhancement). There is a general lack of data on herb-drug interactions. As such, more rigorous scientific research is urgently needed to guide clinical practice as well as to safeguard the wellbeing of diabetes patients.

Keywords: Antidiabetic drugs; Antidiabetic herbs; Herb–drug interactions; Pharmacodynamics interaction; Pharmacokinetic interaction; Synergism.

Figures

Fig. 1
Fig. 1
Mechanisms of action of herb–drug interactions

References

    1. Rahelic D. 7th edition of Idf diabetes Atlas-call for immediate action. Lijec Vjesn. 2016;138(1–2):57–58.
    1. Rawal LB, Tapp RJ, Williams ED, Chan C, Yasin S, Oldenburg B. Prevention of type 2 diabetes and its complications in developing countries: a review. Int J Behav Med. 2012;19(2):121–133. doi: 10.1007/s12529-011-9162-9.
    1. Australian Institute of Health and Welfare . Cardiovascular disease, diabetes and chronic kidney disease-Australian facts: mortality. Cardiovascular, diabetes and chronic kidney disease. Canberra: AIHW; 2014.
    1. Haynes RB, Taylor DW, Sackett DL. Compliance in health care. Baltimore: Johns Hopkins University Press; 1979.
    1. Chang HY, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people living with diabetes: literature review. J Adv Nurs. 2007;58(4):307–319. doi: 10.1111/j.1365-2648.2007.04291.x.
    1. Kiran M, Bernard C, Trisha D. The use of complementary and alternative medicine among people with diabetes in Sydney. BMC Complement Altern Med. 2012;12:2.
    1. Qi LW, Liu EH, Chu C, Peng YB, Cai HX, Li P. Anti-diabetic agents from natural products—an update from 2004 to 2009. Curr Top Med Chem. 2010;10(4):434–457. doi: 10.2174/156802610790980620.
    1. Ghorbani A. Clinical and experimental studies on polyherbal formulations for diabetes: current status and future prospective. J Integr Med. 2014;12(4):336–345. doi: 10.1016/S2095-4964(14)60031-5.
    1. Samad A, Shams MS, Ullah Z, Wais M, Nazish I, Sultana Y, Aqil M. Status of herbal medicines in the treatment of diabetes: a review. Curr Diabetes Rev. 2009;5(2):102–111. doi: 10.2174/157339909788166837.
    1. Gray AM, Flatt PR. Actions of the traditional anti-diabetic plant, Agrimony eupatoria (agrimony): effects on hyperglycaemia, cellular glucose metabolism and insulin secretion. Br J Nutr. 1998;80(1):109–114. doi: 10.1017/S0007114598001834.
    1. Isnard Bagnis C, Deray G, Baumelou A, Le Quintrec M, Vanherweghem JL. Herbs and the kidney. Am J Kidney Dis. 2004;44(1):1–11. doi: 10.1053/j.ajkd.2004.02.009.
    1. Al-Ali M, Wahbi S, Twaij H, Al-Badr A. Tribulus terrestris: preliminary study of its diuretic and contractile effects and comparison with Zea mays. J Ethnopharmacol. 2003;85(2–3):257–260. doi: 10.1016/S0378-8741(03)00014-X.
    1. Colalto C. Herbal interactions on absorption of drugs: mechanisms of action and clinical risk assessment. Pharmacol Res. 2010;62(3):207–227. doi: 10.1016/j.phrs.2010.04.001.
    1. Rodriguez-Landa JF, Contreras CM. A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts. Phytomed Int J Phytother Phytopharmacol. 2003;10(8):688–699. doi: 10.1078/0944-7113-00340.
    1. Lambrecht JE, Hamilton W, Rabinovich AA. Review of herb–drug interactions: documented and theoretical. US Pharmacist. 2000;25:42–53.
    1. Mochiki E, Yanai M, Ohno T, Kuwano H. The effect of traditional Japanese medicine (Kampo) on gastrointestinal function. Surg Today. 2010;40(12):1105–1111. doi: 10.1007/s00595-010-4388-8.
    1. Tokita Y, Yuzurihara M, Sakaguchi M, Satoh K, Kase Y. The pharmacological effects of Daikenchuto, a traditional herbal medicine, on delayed gastrointestinal transit in rat postoperative ileus. J Pharmacol Sci. 2007;104(4):303–310. doi: 10.1254/jphs.FP0070831.
    1. Qi QH, Wang J, Liang GG, Wu XZ. Da-Cheng-Qi-Tang promotes the recovery of gastrointestinal motility after abdominal surgery in humans. Dig Dis Sci. 2007;52(6):1562–1570. doi: 10.1007/s10620-007-9751-2.
    1. Yang XX, Hu ZP, Duan W, Zhu YZ, Zhou SF. Drug-herb interactions: eliminating toxicity with hard drug design. Curr Pharm Des. 2006;12(35):4649–4664. doi: 10.2174/138161206779010440.
    1. Purwantiningsih HAH, Ismail S, Chan KL. Inhibitory effect of Eurycoma longifolia extract and eurycomanone on human cytochrome p450 isoforms. Int J Pharm Sci. 2014;6:441–444.
    1. Fasinu PS, Gutmann H, Schiller H, James AD, Bouic PJ, Rosenkranz B. The potential of Sutherlandia frutescens for herb–drug interaction. Drug Metab Dispos. 2013;41(2):488–497. doi: 10.1124/dmd.112.049593.
    1. Fasinu PS, Gutmann H, Schiller H, Bouic PJ, Rosenkranz B. The potential of Hypoxis hemerocallidea for herb–drug interaction. Pharm Biol. 2013;51(12):1499–1507. doi: 10.3109/13880209.2013.796393.
    1. Mills E, Montori V, Wu P, Gallicano K, Clarke M, Guyatt G. Interaction of St John’s wort with conventional drugs: systematic review of clinical trials. Br Med J. 2004;329:27–30. doi: 10.1136/bmj.329.7456.27.
    1. Nasri H, Shirzad H, Baradaran A, Rafieian-Kopaei M. Antioxidant plants and diabetes mellitus. J Res Med Sci. 2015;20(5):491–502. doi: 10.4103/1735-1995.163977.
    1. Nasri H, Rafieian-Kopaei M. Protective effects of herbal antioxidants on diabetic kidney disease. J Res Med Sci. 2014;19(1):82–83.
    1. Bahmani M, Zargaran A, Rafieian-Kopaei M, Saki K. Ethnobotanical study of medicinal plants used in the management of diabetes mellitus in the Urmia, Northwest Iran. Asian Pac J Trop Med. 2014;7S1:S348–354. doi: 10.1016/S1995-7645(14)60257-1.
    1. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281(21):2005–2012. doi: 10.1001/jama.281.21.2005.
    1. Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65(3):385–411. doi: 10.2165/00003495-200565030-00005.
    1. Hermann LS, Lindberg G, Lindblad U, Melander A. Efficacy, effectiveness and safety of sulphonylurea–metformin combination therapy in patients with type 2 diabetes. Diabetes Obes Metab. 2002;4(5):296–304. doi: 10.1046/j.1463-1326.2002.00189.x.
    1. Jovanovic L, Hassman DR, Gooch B, Jain R, Greco S, Khutoryansky N, Hale PM. Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone. Diabetes Res Clin Pract. 2004;63(2):127–134. doi: 10.1016/j.diabres.2003.09.004.
    1. Del Prato S, Bianchi C, Marchetti P. Beta-cell function and anti-diabetic pharmacotherapy. Diabetes Metab Res Rev. 2007;23(7):518–527. doi: 10.1002/dmrr.770.
    1. Chang CL, Lin Y, Bartolome AP, Chen YC, Chiu SC, Yang WC. Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Altern Med eCAM. 2013;2013:378657.
    1. Mishra R, MohdShuaib S, Shiravan S, Mishra PS. A review on herbal antidiabetic drugs. J App Pharma Sci. 2011;01:235–237.
    1. Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed. 2012;2(4):320–330. doi: 10.1016/S2221-1691(12)60032-X.
    1. Okoli CO, Obidike IC, Ezike AC, Akah PA, Salawu OA. Studies on the possible mechanisms of antidiabetic activity of extract of aerial parts of Phyllanthus niruri. Pharm Biol. 2011;49(3):248–255. doi: 10.3109/13880209.2010.501456.
    1. Hong SH, Heo JI, Kim JH, Kwon SO, Yeo KM, Bakowska-Barczak AM, Kolodziejczyk P, Ryu OH, Choi MK, Kang YH, et al. Antidiabetic and Beta cell-protection activities of purple corn anthocyanins. Biomol Ther (Seoul) 2013;21(4):284–289. doi: 10.4062/biomolther.2013.016.
    1. Ni Y, Turner D, Yates KM, Tizard I. Isolation and characterization of structural components of Aloe vera L. leaf pulp. Int Immunopharmacol. 2004;4(14):1745–1755. doi: 10.1016/j.intimp.2004.07.006.
    1. Yimam M, Zhao J, Corneliusen B, Pantier M, Brownell LA, Jia Q. UP780, a chromone-enriched aloe composition improves insulin sensitivity. Metab Syndr Relat Disord. 2013;11(4):267–275. doi: 10.1089/met.2012.0135.
    1. Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomed Int J Phytother Phytopharmacol. 1996;3(3):245–248. doi: 10.1016/S0944-7113(96)80061-4.
    1. Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomed Int J Phytother Phytopharmacol. 1996;3(3):241–243. doi: 10.1016/S0944-7113(96)80060-2.
    1. Rheman S, Choi M, Choe K, Yoo H. Interactions between herbs and antidiabetics an overview of the mechanisms, evidence, importance and management. Arch Pharm Res. 2015;38:1281–1298. doi: 10.1007/s12272-014-0517-z.
    1. Xiong Y, Shen L, Liu KJ, Tso P, Xiong Y, Wang G, Woods SC, Liu M. Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes. 2010;59(10):2505–2512. doi: 10.2337/db10-0315.
    1. Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2006;550(1–3):173–179. doi: 10.1016/j.ejphar.2006.08.056.
    1. Lee WK, Kao ST, Liu IM, Cheng JT. Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats. Clin Exp Pharmacol Physiol. 2006;33(1–2):27–32. doi: 10.1111/j.1440-1681.2006.04319.x.
    1. Yoon SH, Han EJ, Sung JH, Chung SH. Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice. Biol Pharm Bull. 2007;30(11):2196–2200. doi: 10.1248/bpb.30.2196.
    1. Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT, et al. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis NMCD. 2008;18(1):46–56. doi: 10.1016/j.numecd.2006.04.003.
    1. Lotlikar MM, Rajarama Rao MR. Pharmacology of a hypoglycemic principle isolated from the fruit of Momordica charantia Linn. Ind J Pharm. 1996;28:129–133.
    1. Tongia A, Tongia SK, Dave M. Phytochemical determination and extraction of Momordica charantia fruit and its hypoglycemic potentiation of oral hypoglycemic drugs in diabetes mellitus (NIDDM) Indian J Physiol Pharmacol. 2004;48(2):241–244.
    1. Poonam T, Prakash GP, Kumar LV. Interaction of Momordica charantia with metformin in diabetic rats. Am J Pharm Toxicol. 2013;8:102–106. doi: 10.3844/ajptsp.2013.102.106.
    1. Vijaya K, Sunitha SP, Husssain JA, Sandhya P, Sujatha D, Gopireddy G. Synergistic antihyperglycemic, antihyperlipidemic and antioxidant effects of Momordica charantia and metformin in streptozotocin induced diabetic rats. World J Pharm Res. 2014;3:1901–1980.
    1. Anonymous. Fruit extract effect pare (Momordica charantia) and metformin against kadar blood glucose wistar rats induced by alloxan: comparison of treatment single and combination. Ther Sci Artic. 2014:1–4.
    1. Roufogalis BD. Zingiber officinale (Genger): a future outlook on it’s potential in prevention and treatment of diabetes and predibaetic states. New J Sci. 2014;2014:1–15. doi: 10.1155/2014/674684.
    1. Rani MP, Krishna MS, Padmakumari KP, Raghu KG, Sundaresan A. Zingiber officinale extract exhibits antidiabetic potential via modulating glucose uptake, protein glycation and inhibiting adipocyte differentiation: an in vitro study. J Sci Food Agric. 2012;92(9):1948–1955. doi: 10.1002/jsfa.5567.
    1. Al-Omaria IL, Afifib FU, Salhaba AS. Therapeutic effect and possible herb drug interactions of ginger (Zingiberofficinale Roscoe, Zingiberaceae) crude extract with glibenclamide and insulin. Pharmacognosy Comm. 2012;2:12–20. doi: 10.5530/pc.2012.1.4.
    1. Arshad M, Ashoka S, Samuel RM, Shabaraya AR. Evaluation of the anti-diabetic activity of glibenclamide in combination with ginger in streptozotocin induced diabetes. Int J Pharm Chem Sci. 2013;2:1339–1342.
    1. Rafieian-Kopaei M, Nasri H. The ameliorative effect of zingiberofficinale in diabetic nephropathy. Iran Red Crescent Med J. 2014;16:1–2.
    1. Guzman-Maldonado SH, Morales-Montelongo AL, Mondragon-Jacobo C, Herrera-Hernandez G, Guevara-Lara F, Reynoso-Camacho R. Physicochemical, nutritional, and functional characterization of fruits xoconostle (Opuntia matudae) pears from Central-Mexico Region. J Food Sci. 2010;75(6):C485–C492. doi: 10.1111/j.1750-3841.2010.01679.x.
    1. Sobieraj DM, Freyer CW. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus. Ann Pharmacother. 2010;44(7–8):1334–1337. doi: 10.1345/aph.1P148.
    1. Anonymous. Nutrition Facts for sesame oil per 100 g, analysis of fats and fatty acids. In: National nutrient database for standard reference release 28 United States Department of Agriculture (USDA); 2014.
    1. Sankar D, Rao MR, Sambandam G, Pugalendi KV. A pilot study of open label sesame oil in hypertensive diabetics. J Med Food. 2006;9(3):408–412. doi: 10.1089/jmf.2006.9.408.
    1. Sankar D, Ali A, Sambandam G, Rao R. Sesame oil exhibits synergistic effect with anti-diabetic medication in patients with type 2 diabetes mellitus. Clin Nutr. 2011;30(3):351–358. doi: 10.1016/j.clnu.2010.11.005.
    1. Basch E, Ulbricht C, Kuo G, Szapary P, Smith M. Therapeutic applications of fenugreek. Altern Med Rev. 2003;8(1):20–27.
    1. Naidu MM, Shyamala BN, Naik JP, Sulochanamma G, Srinivas P. Chemical composition and antioxidant activity of the husk and endosperm of fenugreek seeds. LWT Food Sci Tech. 2010;44:451–456. doi: 10.1016/j.lwt.2010.08.013.
    1. Neha S, Anand K, Sunanda P. Administration of fenugreek seed extract produces better effects in the glibenclamide-induced inhibition in hepatic lipid peroxidation: an in vitro study. Chin J Integr Med. 2015;21:1.
    1. Lawson LD, Cardner CD. Composition, stability and bioavailability of garlic products being used in a clinical trial. J Agric Food Chem. 2005;53:6254–6261. doi: 10.1021/jf050536+.
    1. Shikha C, Tamanna N, Kumar SL. Effect of Allium Sativumon the pharmacokinetic of Metformin in rat plasma: a herb–drug interaction study. Der Pharm Chem. 2011;3:287–291.
    1. Poonam T, Prakash GP, Kumar LV. Effect of co-administration of Allium sativum extract and Metformin on Blood glucose of Streptozotocin induced diabetic rats. J Intercult Ethnopharmacol. 2013;2:81–84. doi: 10.5455/jice.20130530123748.
    1. Rafieian-Kopaei M, Baradaran A, Merrikhi A, Nematbakhsh M, Madihi Y, Nasri H. Efficacy of Co-administration of garlic extract and metformin for prevention of gentamicin-renal toxicity in wistar rats: a biochemical study. Int J Prev Med. 2013;4(3):258–264.
    1. Tavafi M. Protection of renal tubules against gentamicin induced nephrotoxicity. J Renal Inj Prev. 2013;2(1):5–6.
    1. Ashraf R, Khan RA, Ashraf I. Garlic (Allium sativum) supplementation with standard antidiabetic agent provides better diabetic control in type 2 diabetes patients. Pak J Pharm Sci. 2011;24(4):565–570.
    1. Fabio GD, Romanucci V, De Marco A, Zarrelli A. Triterpenoids from Gymnemasylvestre and their pharmacological activities. Molecules. 2014;19:10956–10981. doi: 10.3390/molecules190810956.
    1. Sugihara Y, Nojima H, Matsuda H, Murakami T, Yoshikawa M, Kimura I. Antihyperglycemic effects of gymnemic acid IV, a compound derived from Gymnema sylvestre leaves in streptozotocin-diabetic mice. J Asian Nat Prod Res. 2000;2(4):321–327. doi: 10.1080/10286020008041372.
    1. Kumar DS, Ramakrishna R. Kannappan.: effect of Gymnemasylvestre on thepharmacokinetics and pharmacodynamics of metformin in diabetic rats. J Pharm Res. 2013;6:657–664.
    1. Raja P, Thejaswini JC, Gurupadayya BM, Mruthyunjaya K, Latha Saranya CH. Evaluation of influence of gymnema tea on antidiabetic activity of metformin in diabetic rats. Indo Am J Pharm Res. 2013;3:12.
    1. Srujan K, Ramakrishna R, Jumar DS. Effect of Gymnemasylvestre extract on the pharmacokinetics and pharmacodynamics of oral hypoglycemic drug—Metformin in hyperglycemic rats. J Pharm Res. 2014;8:614–620.
    1. Sweety M. Pharmacognosy of St. John’s Wort. . Accessed 25 Feb 2017.
    1. Stage TB, Pedersen RS, Damkier P, Christensen MM, Feddersen S, Larsen JT, Hojlund K, Brosen K. Intake of St John’s wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone. Br J Clin Pharmacol. 2015;79(2):298–306. doi: 10.1111/bcp.12510.
    1. Fan L, Zhou G, Guo D, Liu YL, Chen WQ, Liu ZQ, Tan ZR, Sheng D, Zhou HH, Zhang W. The pregnane X receptor agonist St John’s Wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide. Clin Pharmacokinet. 2011;50(9):605–611. doi: 10.2165/11587310-000000000-00000.
    1. Lin LZ, He XG, Lindenmaier M, Nolan G, Yang J, Cleary M, Qiu SX, Cordell GA. Liquid chromatography-electrospray ionization mass spectrometry study of the flavonoids of the roots of Astragalus mongholicus and A. membranaceus. J Chromatogr A. 2000;876(1–2):87–95. doi: 10.1016/S0021-9673(00)00149-7.
    1. Shi Z, Gao J, Yuan Y, Zhu S, Yao M. Effect of raw Radix Rehmanniae on the pharmacokinetics of pioglitazone in rats. Pak J Pharm Sci. 2014;27(3):537–539.
    1. Yang LX, Liu D, Feng XF, Zhu SL, Yang YJ, Tang XJ, He XR, Liu JF, Hu SL. Determination of flavone for Scutellariabaicalensis from different areas by HPLC. Zhongguo Zhong Yao ZaZhi (in Chinese) 2002;27:166–170.
    1. Reyes BA, Bautista ND, Tanquilut NC, Anunciado RV, Leung AB, Sanchez GC, Magtoto RL, Castronuevo P, Tsukamura H, Maeda KI. Anti-diabetic potentials of Momordica charantia and Andrographis paniculata and their effects on estrous cyclicity of alloxan-induced diabetic rats. J Ethnopharmacol. 2006;105(1–2):196–200. doi: 10.1016/j.jep.2005.10.018.
    1. Yu BC, Chen WC, Cheng JT. Antihyperclycaemic effect of andrographolide in streptozotocin-induced diabetic rats. Planta Med. 2003;69:1075–1079. doi: 10.1055/s-2003-45185.
    1. Pan Y, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Pook PC, Er HM, Ong CE. In vitro determination of the effect of Andrographis paniculata extracts and andrographolide on human hepatic cytochrome P450 activities. J Nat Med. 2011;65(3–4):440–447. doi: 10.1007/s11418-011-0516-z.
    1. Wu H, Guo H, Zhao R. Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats. Yakugaku Zasshi. 2005;125:981–988. doi: 10.1248/yakushi.125.981.
    1. Williamson EM, Driver S, Baxter K, Lee CR. Stockley’s herbal medicine interactions. London: Pharmaceutical Press; 2013.
    1. Nirmala A, Eliza I, Rajalakshimi M, Priya E, Daisy P. Effect of hexane extract of Cassia fstula barks on blood glucose and lipid profile in streptozotocin diabetic rats. Int J Pharmacol. 2008;4:292–296. doi: 10.3923/ijp.2008.292.296.
    1. Malpani SN, Manjunath KP, Sholapur H, Savadi RV, Akki KS, Darade SS. Antidiabetic activity of Cassia fistula Linn. bark in alloxan induced diabetic rats. Int J Pharm Sci Res. 2010;2:382–385.
    1. Appiah-Opong R, Commanduer JN, Axson C, Vermeulen NP. Interactions between cytochromes P450, glutathione S-transferases and Ghanaian medicinal plants. Food Chem Toxicol. 2008;46:3598–3603. doi: 10.1016/j.fct.2008.09.002.
    1. El SN, Karakaya S. Olive tree (Olea europaea) leaves: potential beneficial effects on human health. Nutr Rev. 2009;67(11):632–638. doi: 10.1111/j.1753-4887.2009.00248.x.
    1. Wainstein J, Ganz T, Boaz M, Bar Dayan Y, Dolev E, Kerem Z, Madar Z. Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. J Med Food. 2012;15(7):605–610. doi: 10.1089/jmf.2011.0243.
    1. Rigacci S, Guidotti V, Bucciantini M, Parri M, Nediani C, Cerbai E, Stefani M, Berti A. Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J Nutr Biochem. 2010;21(8):726–735. doi: 10.1016/j.jnutbio.2009.04.010.
    1. Carella A, Marinelli T, Melfitano A, Di Pumpo M, Conte M, Benvenuto A. Hypoglycemia by Ginseng in type 2 Diabetic Patient: case Report. Heighpubs Obes Diabetes Metab Syndr. 2017;1:001–006.
    1. Rhoades KR. Prescribed medications and OTCs: interactions and thiming issues. Diabetes Spectrum. 2002;15:256–261. doi: 10.2337/diaspect.15.4.256.
    1. Bushra R, Aslam B, Khan AY. Food–drug interactions. Oman Med J. 2011;26:77–83. doi: 10.5001/omj.2011.21.
    1. Cho HJ, Yoon IS. Pharmacokinetic interactions of herbs with cytochrome p450 and p-glycoprotein. Evid Based Complement Altern Med eCAM. 2015;2015:736431.
    1. Zhou SF, Li ZW, Chen CG, Yu X, Xue Q, Herrington CC. Identification of drugs that interact with herbs in drug development. Adrian Drug Disc Today. 2015;12:664–673. doi: 10.1016/j.drudis.2007.06.004.
    1. Zhou X, Seto SW, Chang D, Kiat H, Razmovski-Naumovski V, Chan K, Bensoussan A. Synergistic effects of Chinese herbal medicine: a comprehensive review of methodology and current research. Front Pharmacol. 2016;7:201.
    1. Brantley SJ, Argikar AA, Lin YS, Nagar S, Paine MF. Herb–drug interactions: challenges and opportunities for improved predictions. Drug Metab Dispos. 2014;42(3):301–317. doi: 10.1124/dmd.113.055236.
    1. Neergheen-Bhujun VS. Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries. Biomed Res Int. 2013;2013:804086. doi: 10.1155/2013/804086.
    1. Kunle OF, Egharevba HO, Ahmadu PO. Standardization of herbal medicines—a review. Int J Biodivers Cons. 2012;4:101–112.
    1. Jyothi M, Joyl G, Kumar A, Naveen K. A review on herbal drug interactions. Int J Pharmacy. 2011;1:18–31.
    1. Lu WI, Lu DP. Impact of chinese herbal medicine on American society and health care system: perspective and concern. Evid Based Complement Altern Med eCAM. 2014;2014:251891.
    1. Bensoussan A, Lee S, Murray C, Bourchier S, van der Kooy F, Pearson JL, Liu J, Chang D, Khoo CS. Choosing chemical markers for quality assurance of complex herbal medicines: development and application of the herb MaRS criteria. Clin Pharmacol Ther. 2015;97(6):628–640. doi: 10.1002/cpt.100.
    1. Ip SP, Zhao M, Xian Y, Chen M, Zong Y, Tjong YW, Tsai SH, Sung JJ, Bensoussan A, Berman B, et al. Quality assurance for Chinese herbal formulae: standardization of IBS-20, a 20-herb preparation. Chin Med. 2010;5:8. doi: 10.1186/1749-8546-5-8.
    1. Arun R, Sravya S, Roja C. A review on standardisation of herbal formulation. Int J Phytother. 2012;2:74–88.
    1. Vaibhav M, Shinde L, Dhalwal K, Manohar P, Kakasaheb R, Mahadik I. Application of quality control principles to herbal drugs. Int J Phytomed. 2009;1:4–8. doi: 10.5138/ijpm.2009.0975.0185.05786.
    1. Kalyankar TM, Wadherl SJ, Dangel SS, Attar MS, Pattewar AM. Analysis of herbal drugs: a review. Asian J Med and Analt Chem. 2014;01:12–20.
    1. Flower A, Witt C, Liu J, Ulrich-Merzenich G, Muir K, Yu H, Prude M, Lweith G. GP-TCM Unabridged guidelines for randomised controlled trials investigating Chinese herbal medicine. Eur J Int Med. 2014;6:186–210. doi: 10.1016/j.eujim.2013.07.011.
    1. Chavez ML, Jordan MA, Chavez PI. Evidence-based drug–herbal interactions. Life Sci. 2006;78(18):2146–2157. doi: 10.1016/j.lfs.2005.12.009.
    1. Del Prete A, Scalera A, Iadevaia MD, Miranda A, Zulli C, Gaeta L, Tuccillo C, Federico A, Loguercio C. Herbal products: benefits, limits, and applications in chronic liver disease. Evid Based Complement Altern Med eCAM. 2012;2012:837939.
    1. Ge B, Zhang Z, Zuo Z. Updates on the clinical evidenced herb–warfarin interactions. Evid Based Complement Altern Med eCAM. 2014;2014:957362.
    1. Hussain S. Counseling about herbal–drug interactions. J Tradit Complement Altern Med. 2011;8:152–163.
    1. Yaheya M, Ismail M. Herb–drug interactions and patient counselling. Int J Pharm Pharmaceut Sci. 2009;1:151–161.
    1. Al-Ramahi R, Jaradat N, Shalalfeh R, Nasir S, Manasra Y, Shalalfeh I, Esam Y. Evaluation of potential drug–herb interactions among a group of Palestinian patients with chronic diseases. BMC Complement Altern Med. 2015;15:221. doi: 10.1186/s12906-015-0764-7.
    1. Al-Arifi MN. Availability and needs of herbal medicinal information resources at community pharmacy, Riyadh region, Saudi Arabia. Saudi Pharm J. 2013;21(4):351–360. doi: 10.1016/j.jsps.2012.11.004.
    1. Rafieian-Kopaei M, Nasri H. The ameliorative effect of Zingiber officinale in diabetic nephropathy. J Renal Inj Prev. 2014;2:9–10.
    1. Viduranga Y, Waisundara AH, Huang D, Tan BK. Scutellariabaicalensis enhances the anti-diabetic activity of metformin in streptozotocin-induced diabetic wistar rats. Am J Chin Med. 2008;36:517–540. doi: 10.1142/S0192415X08005953.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe